tiprankstipranks
Trending News
More News >
Janux Therapeutics, Inc. (JANX)
NASDAQ:JANX
US Market

Janux Therapeutics Inc (JANX) Income Statement

Compare
712 Followers

Janux Therapeutics Inc Income Statement

Last quarter (Q4 2025), Janux Therapeutics Inc's total revenue was $7.88M, an increase of Infinity% from the same quarter last year. In Q4, Janux Therapeutics Inc's net income was $-31.95M. See Janux Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 10.00M$ 10.59M$ 8.08M$ 8.61M$ 3.64M
Gross Profit
$ 7.97M$ 8.53M$ 6.13M$ 7.77M$ 3.64M
Operating Expenses
$ 165.64M$ 107.38M$ 79.11M$ 74.86M$ 36.57M
Depreciation and Amortization
$ 2.03M$ 2.06M$ 1.96M$ 841.00K$ 113.00K
EBITDA
$ -111.60M$ -96.79M$ -71.02M$ -66.25M$ -32.82M
Operating Income
$ -157.67M$ -98.85M$ -72.98M$ -67.09M$ -32.93M
Other Income/Expenses
$ 44.04M$ 29.85M$ 14.69M$ 4.03M$ 257.00K
Pretax Income
$ -113.63M$ -68.99M$ -58.29M$ -63.06M$ -32.67M
Net Income
$ -113.63M$ -68.99M$ -58.29M$ -63.06M$ -32.67M
Per Share Metrics
Basic EPS
$ -1.83$ -1.28$ -1.32$ -1.52$ -0.79
Diluted EPS
$ -1.83$ -1.28$ -1.32$ -1.52$ -0.79
Weighted Average Shares Outstanding
61.97M 53.75M 44.02M 41.47M 41.24M
Weighted Average Shares Outstanding (Diluted)
61.97M 53.75M 44.02M 41.47M 41.24M
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History